Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Dario Scimeca

General Counsel at Precision Biosciences Inc (DTIL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $59K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 19SEC DTILPrecision Biosciences Inc Sell Plan 4,92556,457 held (−8%) $3.84 $19K +50.3%
Jan 22SEC DTILPrecision Biosciences Inc Sell Plan 8,85444,715 held (−17%) $4.03 $36K +43.2%
Nov 4SEC DTILPrecision Biosciences Inc Sell Plan 66528,258 held (−2%) $6.49 $4K -11.1%
  • Sell

    General Counsel Dario Scimeca sold $19K of DTIL at $3.84 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Dario Scimeca sold $36K of DTIL at $4.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    General Counsel Dario Scimeca sold $4K of DTIL at $6.49 — pre-scheduled 10b5-1 plan sale.